Zilbrysq Side Effects
Generic name: zilucoplan
Medically reviewed by Drugs.com. Last updated on Apr 13, 2023.
Note: This document contains side effect information about zilucoplan. Some dosage forms listed on this page may not apply to the brand name Zilbrysq.
Applies to zilucoplan: subcutaneous solution.
General
The most common adverse effects in at least 10% of patients were injection site reactions, upper respiratory tract infections, and diarrhea.[Ref]
Gastrointestinal
Pancreatic events included pancreatitis and pancreatic cysts.[Ref]
Very common (10% or more): Diarrhea (11%)
Common (1% to 10%): Nausea, vomiting
Frequency not reported: Pancreatic events[Ref]
Genitourinary
Common (1% to 10%): Urinary tract infection[Ref]
Local
Very common (10% or more): Injection site reactions (29%)
Other
Common (1% to 10%): Increased lipase, increased amylase
Frequency not reported: Meningococcal infection, transient elevations of blood eosinophils[Ref]
Respiratory
Very common (10% or more): Upper respiratory tract infections (14%)[Ref]
More about Zilbrysq (zilucoplan)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
References
1. Product Information. Zilbrysq (zilucoplan). UCB Pharma Inc. 2023.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.
